CMMB - Chemomab Therapeutics - ADR EPS beats by $0.01 November, 12 2021 08:54 AM Chemomab Therapeutics Ltd. Chemomab Therapeutics - ADR (NASDAQ:CMMB): Q3 GAAP EPS of -$0.01 beats by $0.01. Cash, cash equivalents of $64.3M Press Release For further details see: Chemomab Therapeutics - ADR EPS beats by $0.01